Refine by
Cancerous Mutation Articles & Analysis
24 articles found
This phenomenon offers a remarkable opportunity in cancer therapy. Tumors often exhibit mutations that can be exploited for targeted treatments. ...
Another critical regulator is the retinoblastoma protein (Rb), which prevents cells from entering the S phase until they are ready. When mutated, Rb loses its ability to control division, often leading to cancer. ...
Colorectal cancer is one of the leading causes of cancer-related deaths globally. ...
Cancer is a worldwide disease and one of the leading causes of morbidity and mortality today. ...
In response to the emerging needs in global healthcare, SOPHiA GENETICS has just revealed the New Generation SOPHiA DDM™ Platform, aiming to stay at the forefront of precision medicine and address today the healthcare needs of tomorrow. ...
Early detection and regular screening are pivotal in perfecting outcomes for patients with breast cancer. Why Breast Cancer Occurs Breast cancer occurs when normal cells in the breast tissue suffer gene mutations that cause them to grow and multiply in an uncontrolled manner. ...
CDH1 loss is particularly significant in epithelial cancers, such as breast, gastric, and colorectal cancers. In breast cancer, for example, the loss of CDH1 expression is associated with a more aggressive phenotype and poorer prognosis. ...
Taking the most used Jak/Stat and NF-kB as examples. Jak/Stat pathway and cancer JAK activating mutations are a major molecular mechanism in malignant hematologic diseases. ...
WES offers a simpler, more cost-effective, and efficient alternative to whole genome sequencing, with higher target region coverage, facilitating accurate variant detection. Enhancing Cancer Genomic Research with WES Mutations occurring within the whole exome regions of the cancer genome play a pivotal role in tumor development. ...
Essentially, it uses a "vacuum cleaner" to clean up errors and remove pre-cancerous material from cells. But if it's mutated, CDK13 can't do its job of RNA surveillance and basically clears out the junk. ...
These large, complex molecules bind to their targets in unique ways, are efficiently taken up by cells, and have the potential to be used to create new drugs to treat cancer and other diseases. Through a combination of functional genomics and chemical approaches, the scientists discovered an endogenous pathway involving interferon-induced transmembrane (IFITM) proteins that ...
Glioblastoma is a deadly brain cancer with a dire prognosis. Unlike most cancers, it still grows in the presence of the p53 protein. ...
Cancer is a heterogenous mixture of diseases characterized by, among other things, the abnormal, uncontrolled growth of cells derived from otherwise healthy tissues (Hanahan 2022). Although cancer cells sometimes grow into balls of cells and stop there (so-called benign tumors), often they gain the ability to disperse throughout the body, seed the growth of other tumors, disrupt the function of a ...
Pancreatic cancer is a highly malignant digestive system tumor, and the five-year survival rate of patients after diagnosis is only about 10%. ...
Diseases And Epigenetic Modifications The occurrence of some diseases has been found to be inextricably linked to epigenetics. Cancer is caused by gene mutations and epigenetic alterations of genes. ...
Background Pancreatic cancer is one of the highest mortality rate cancers worldwide with 5-year relative survival of 10.8%. ...
Genetic mutations in cells are an important cause of cancer development, progression, and drug resistance. ...
Since mitochondria play an important role in the maintenance of homeostasis, their abnormal function is associated with many human diseases, such as neurodegenerative diseases, cancer, heart disease and diabetes. Mutations in more than 350 genes of mitochondrial and nuclear origin have been reported, resulting in mitochondrial diseases. ...
Abstract The oncogene Ras and the tumor suppressor gene p53 are frequently co-mutated in human cancer and mutations in Ras and p53 can cooperate to generate a more malignant cell state. To discover novel druggable targets for cancers carrying co-mutations in Ras and p53, we performed arrayed, kinome focused ...
As cancer-related mutations are cumulatively being identified and characterized, the variety of cancer gene panels is increasing. ...